Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Feb;25(2):179-84.
doi: 10.1038/nbt0207-179.

Turning biodefense dollars into products

Melanie C Trull  1 , Tracey V du Laney, Mark D Dibner
Affiliations
Review

Turning biodefense dollars into products

Melanie C Trull et al. Nat Biotechnol. 2007 Feb.

Abstract

Five years after the US anthrax attacks, and more than two years after BioShield legislation was ratified, a survey reveals that biodefense funding has thus far produced only a handful of products for clinical development.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Biodefense vaccines in development.
Figure 2
Figure 2
Biodefense therapeutics in development.
None
President Bush encourages the US Congress to pass BioShield legislation. AFP Photo/Luke Frazza
See this image and copyright information in PMC

References

    1. Trull MC, du Laney TV, Dibner MD. BioAbility/BioWorld. 2006.
    1. HHS cancels VaxGen's anthrax vaccine contract. (VaxGen, Brisbane, CA, December 19, 2006). http://biz.yahoo.com/prnews/061219/sftu092.html?.v=78
    1. Warrick J. The Washington Post. 2006. The secretive fight against bioterror; p. pA01.
    1. http://www.cdc.gov/ncidod/diseases/hepatitis/a/fact.htm
    1. Trull MC, du Laney TV, Dibner MD. BioAbility/BioWorld. 2005. Biodefense market report: drugs and vaccines for bioterror agents.